Abstract
Although previous studies suggested that the expression of FMS-like tyrosine kinase 3 (Flt3) initiates downstream of mouse hematopoietic stem cells (HSCs), FLT3 internal tandem duplications (FLT3 ITDs) have recently been suggested to intrinsically suppress HSCs. Herein, single-cell interrogation found Flt3 mRNA expression to be absent in the large majority of phenotypic HSCs, with a strong negative correlation between Flt3 and HSC-associated gene expression. Flt3-ITD knock-in mice showed reduced numbers of phenotypic HSCs, with an even more severe loss of long-term repopulating HSCs, likely reflecting the presence of non-HSCs within the phenotypic HSC compartment. Competitive transplantation experiments established that Flt3-ITD compromises HSCs through an extrinsically mediated mechanism of disrupting HSC-supporting bone marrow stromal cells, with reduced numbers of endothelial and mesenchymal stromal cells showing increased inflammation-associated gene expression. Tumor necrosis factor (TNF), a cell-extrinsic potent negative regulator of HSCs, was overexpressed in bone marrow niche cells from FLT3-ITD mice, and anti-TNF treatment partially rescued the HSC phenotype. These findings, which establish that Flt3-ITD–driven myeloproliferation results in cell-extrinsic suppression of the normal HSC reservoir, are of relevance for several aspects of acute myeloid leukemia biology.
Funding Information
  • Bloodwise
  • Medical Research Council (MR/L006340/1)
  • MRC (G0801073, MC_UU_12009/5)
  • Swedish Research Council
  • Bloodwise
  • Wellcome Trust
  • MRC
  • Oxford Consortium for Single-Cell Biology (MR/M00919X/1)
  • WIMM Flow Cytometry Facility
  • MRC
  • Human Immunology Unit
  • MRC
  • Molecular Haematology Unit (MC_UU_12009)
  • National Institute for Health Research
  • Oxford Biomedical Research Centre
  • John Fell Fund (131/030, 101/517)
  • E.P. Abraham Research Fund (CF182, CF170)
  • WIMM Strategic Alliance (G0902418, MC_UU_12025)

This publication has 58 references indexed in Scilit: